PUMA BIOTECHNOLOGY, INC. Other Current Assets
PUMA BIOTECHNOLOGY, INC. (PBYI) had Other Current Assets of $199.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-06
- 2026-06-30: Other Assets, Current $199.00K.
- 2026-03-31: Other Assets, Current $196.00K.
- 2025-12-31: Other Assets, Current $256.00K.
- 2025-09-30: Other Assets, Current $230.00K.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $199.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $196.00K 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $256.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $230.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $73.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $98.00K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $91.00K 10-K · filed 2026-02-26 | |
| 2024-09-30 | $236.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $241.00K 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $255.00K 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $912.00K 10-K · filed 2025-02-27 | |
| 2023-09-30 | $1.99M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $573.00K 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $449.00K 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $2.43M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $4.11M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $4.29M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $631.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $447.00K 10-K · filed 2023-03-02 | |
| 2021-09-30 | $451.00K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $478.00K 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $373.00K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $3.64M 10-K · filed 2022-03-03 | $3.44M 10-K · filed 2021-03-01 |
| 2020-09-30 | $3.43M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $3.43M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $305.00K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $323.00K 10-K · filed 2021-03-01 | |
| 2019-09-30 | $322.00K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $330.00K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $10.15M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $1.79M 10-K · filed 2020-02-28 | |
| 2018-09-30 | $11.49M 10-Q · filed 2018-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |